Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CAMLOG Biotechnologies is a commercial-stage dental implant and restorative dentistry company focused on premium implant systems, prosthetic components, digital workflows, and regenerative materials for oral reconstruction. The company develops implant systems and workflow solutions in Basel, Switzerland, while manufacturing is carried out by ALTATEC GmbH in Wimsheim, Germany. CAMLOG products are sold in more than 90 countries, and the business operates in close alignment with BioHorizons under the BioHorizons Camlog brand alliance. Its portfolio includes the CAMLOG, CONELOG, CERALOG, and iSy implant systems, along with biomaterials used in implant dentistry. CAMLOG is part of Henry Schein's Global Dental Surgical Group and functions as an operating subsidiary in the dental medical technology market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CAMLOG Biotechnologies.